The Analysis of Decheng Capital LLC's Holdings
Currently, Decheng Capital LLC holds 19 types of securities in its portfolio with a total value $743.4M. In the most recent quarter, they have increased their positions in N/A (+96.6K shares, valued at $3.0M); decreased their positions in UPB (-142.2K shares, valued at $3.9M), KRYS (-15.0K shares, valued at $3.7M), CRNX (-50.3K shares, valued at $2.3M). Stock Holdings
TickerCompany NameSharesShares âŗ%Event DateReport DateHistory
CGON CG ONCOLOGY INC6.4M shares0.00%2025-12-312026-02-12
NUVB Nuvation Bio Inc.26.0M shares0.00%2025-12-312026-02-12 UPB Upstream Bio Inc.3.1M shares-4.33%2025-12-312026-02-12 AARD AARDVARK THERAPEUTICS INC3.9M shares0.00%2025-12-312026-02-12 NAMS NEWAMSTERDAM PHARMA CO NV592.1K shares-9.89%2025-12-312026-02-12 RVMD REVOLUTION MEDICINES INC(NSM)200.0K shares-4.76%2025-12-312026-02-12 RCUS Arcus Biosciences, Inc541.6K shares-1.10%2025-12-312026-02-12 ACRS Aclaris Therapeutics, Inc.4.0M shares0.00%2025-12-312026-02-12 EQ Equillium Inc.4.4M shares0.00%2025-12-312026-02-12 BYSI BeyondSpring Inc.3.8M shares-11.33%2025-12-312026-02-12 CRNX CRINETICS PHARMACEUTICALS IN92.7K shares-35.17%2025-12-312026-02-12 KRYS KRYSTAL BIOTECH INC17.3K shares-46.44%2025-12-312026-02-12 AURA Aura Biosciences, Inc.360.5K shares-30.08%2025-12-312026-02-12 ZNTL Zentalis Pharmaceuticals Inc.1.3M shares0.00%2025-12-312026-02-12 PYXS Pyxis Oncology, Inc (formerly Apexigen)326.8K shares0.00%2025-12-312026-02-12 FDMT 4D MOLECULAR THERAPEUTICS IN44.3K shares-52.22%2025-12-312026-02-12 NUVB.WS Nuvation Bio Inc.646.1K shares0.00%2025-12-312026-02-12 RZLT REZOLUTE INC59.9K shares0.00%2025-12-312026-02-12 Call Option Holdings
No call option holdings data available
Put Option Holdings
No put option holdings data available